(Q42212558)

English

A novel peptide-based pan-influenza A vaccine: a double blind, randomised clinical trial of immunogenicity and safety.

scientific article published on 10 June 2014

Statements

A novel peptide-based pan-influenza A vaccine: a double blind, randomised clinical trial of immunogenicity and safety (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit